Wall Street Analysts See a 280.14% Upside in MBX Biosciences, Inc. (MBX): Can the Stock Really Move This High?

MBX Biosciences, Inc. (MBX) closed the last trading session at $15.86, gaining 54.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $60.29 indicates a 280.1% upside potential.The mean estimate comprises seven short-term price targets with a standard deviation of $18.94. While the lowest estimate of $30.00 indicates an 89.2% increase from the current price level, the most optimisti ...